Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T08:56:53.305Z Has data issue: false hasContentIssue false

Radiographic properties of injected calcium hydroxylapatite: potential false positive findings on positron emission tomography

Published online by Cambridge University Press:  18 March 2008

E J Damrose*
Affiliation:
Division of Laryngology, Department of Otolaryngology/Head and Neck Surgery, Stanford University Medical Center, Stanford, California, USA
*
Address for correspondence: Dr Edward J Damrose, Division of Laryngology, Department of Otolaryngology/Head and Neck Surgery, Stanford University Medical Center, 801 Welch Road, Stanford, CA 94305, USA. Fax: +1 650 725 8502 E-mail: edamrose@stanford.edu
Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To describe the positron emission tomography and computed tomography features of injected calcium hydroxylapatite, and to discuss how these may be mistaken for malignancy.

Case report:

Positron emission tomography is now readily employed in the staging and monitoring of patients with head and neck carcinoma. Concomitant with the growing use of this modality has been the increasing popularity of injected calcium hydroxylapatite to treat glottic incompetence secondary to vocal fold paralysis or following partial laryngectomy. A patient developed aspiration following near-total laryngectomy and subsequently underwent injection of calcium hydroxylapatite, with effective resolution of the aspiration. The patient underwent positron emission tomography scanning as part of routine tumour surveillance; this showed intense tracer uptake at the site of injection, and this pattern persisted for one year following injection.

Conclusions:

As injectable calcium hydroxylapatite becomes more widely used, especially in the treatment of patients with a history of head and neck cancer, physicians should be aware it may cause a potentially misleading, false positive positron emission tomography finding.

Information

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2008
Figure 0

Fig. 1(a) Axial computed tomography scan showing calcium hydroxylapatite injected into the pharyngeal aspect of a myomucosal shunt; calcium particles appear bright white (arrow). (b) Corresponding positron emission tomography image, showing intense 18F-deoxyglucose uptake at injection site (arrow).

Figure 1

Fig. 2Imaging scans taken one year after injection. (a) Axial computed tomography scan showing that much of the injected calcium hydroxylapatite has been reabsorbed (arrow). (b) Corresponding positron emission tomography image, showing intense 18F-deoxyglucose uptake persisting at the injection site (arrow).